PD-L1 POSITIVE
Clinical trials for PD-L1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PD-L1 POSITIVE trials appear
Sign up with your email to follow new studies for PD-L1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double-Punch cancer trial tests vaccine & immune boosters
Disease control OngoingThis study is testing whether combining a cancer vaccine (CIMAvax) with immunotherapy drugs (nivolumab or pembrolizumab) is safe and effective for people with advanced non-small cell lung cancer or squamous head and neck cancer. The goal is to help the body's immune system better…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
New hope for tough breast cancer: Two-Drug combo enters final testing
Disease control OngoingThis study is testing if a new drug combination works better than current standard treatments for people with a hard-to-treat type of advanced breast cancer. It involves 443 adults with triple-negative breast cancer that has spread and who have not yet received treatment for thei…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC